Posted: 20 January 2023 |
Principal Microbiologist, New Modalities and Parenteral Development. Pharmaceutical Technology and Development, Global Operations, AstraZeneca UK.
Miriam has worked in pharmaceutical development for over 20 years, in both microbiology and formulation laboratories and GMP manufacturing environments; more recently supporting complex supply chains and designing robust control strategies, including the associated regulatory authoring and interactions. She leads the AZ Global Microbiology Forum, bringing together the global network of microbiology labs to drive standardisation and quality principals in microbiology.
Miriam devised and leads AstraZeneca’s “21st Century Microbiology Strategy”, to innovate, industrialise and implement technology solutions to drive efficiencies and process robustness benefits within the AZ global network. She is an active committee member of the Pharmaceutical Microbiology Interest Group (Pharmig) and is involved in various cross industry collaborative groups.
Miriam has two teenage daughters and enjoys playing football in her spare time.